IOL Chemicals and Pharmaceuticals share news, announcements and annual reports
NSE: IOLCPBSE: 524164Pharmaceuticals & BiotechnologySmall Cap
IOL Chemicals and Pharmaceuticals Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Feb 1991 on BSE, Nov 2010 on NSE
Last close ₹177.65down ₹7.28 (3.94%)BSE ₹177.75
Share price at the NSE close on 30 Oct 2026. Previous close ₹184.93.
30 Oct: open ₹186.40, high ₹186.40, low ₹176.02
52-week range of traded prices to 30 Oct 2026
₹67.19Low, 16 Mar 2026₹224.00High, 7 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹5,215 Cr1,024th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 25.66
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.71
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.56%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 11.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 13.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.10
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 18,08,91234.0% delivered
IOL Chemicals and Pharmaceuticals has 709 announcements on record, routine notices left out; 4 in the 30 days to 31 Oct 2026, the latest on 30 Oct 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.IOL Chemicals and Pharmaceuticals quarterly results
Oct30Fri
The board met on 30 Oct 2026 to consider financial results
Notice filed 23 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
IOL Chemicals and Pharmaceuticals annual reports, presentations and earnings calls
The company's own documents, latest first.IOL Chemicals and Pharmaceuticals financials, year by year
Annual reports15
- Annual report, year to Mar 20267 Aug 2026
- Annual report, year to Mar 202531 Jul 2025
- Annual report, year to Mar 20241 Aug 2024
- Annual report, year to Mar 202319 Jul 2023, a zip file
- Annual report, year to Mar 20223 Aug 2022, a zip file
10 earlier reports
- Annual report, year to Mar 202125 Aug 2021, a zip file
- Annual report, year to Mar 20201 Sep 2020, a zip file
- Annual report, year to Mar 201930 Jul 2019, a zip file
- Annual report, year to Mar 20186 Oct 2018, a zip file
- Annual report, year to Mar 201729 Sep 2017, a zip file
- Annual report, year to Mar 20168 Oct 2016, a zip file
- Annual report, year to Mar 201510 Sep 2015, a zip file
- Annual report, year to Mar 20143 Sep 2014, a zip file
- Annual report, year to Mar 201322 Nov 2013, a zip file
- Annual report, year to Mar 201215 Oct 2013, a zip file
Investor presentations27
- Investor Presentation12 Aug 2026
- Investor Presentation21 May 2026
- Investor Presentation12 Feb 2026
- Investor Presentation12 Nov 2025
- Investor Presentation7 Aug 2025
22 earlier presentations
- Investor Presentation19 May 2025
- Investor Presentation13 Feb 2025
- Investor Presentation18 Nov 2024
- Investor Presentation12 Aug 2024
- Investor Presentation15 May 2024
- Investor Presentation7 Feb 2024
- Investor Presentation9 Nov 2023
- Investor Presentation14 Aug 2023
- Presentation at B&K Securities Trinity India Conference3 Jun 2023
- Investor Presentation8 May 2023
- Investor Presentation8 Feb 2023
- Investor Presentation15 Nov 2022
- Investor Presentation10 Aug 2022
- Investor Presentation31 May 2022
- Investor Presentation7 Feb 2022
- Investor Presentation15 Nov 2021
- Investor Presentation19 Aug 2021
- Investor Presentation14 Jun 2021
- Investor Presentation16 Feb 2021
- Investor Presentation10 Nov 2020
- Investor Presentation10 Nov 2020
- Corporate Presentation for the information of the Investors.9 Sep 2016, a zip file
Earnings calls42
- Transcript17 Sep 2026
- Link of Recording11 Sep 2026
- Transcript20 Aug 2026
- Link of Recording13 Aug 2026
- Transcript28 May 2026
37 earlier call documents
- Link of Recording22 May 2026
- Transcript18 Feb 2026
- Link of Recording12 Feb 2026
- Transcript19 Nov 2025
- Link of Recording13 Nov 2025
- Transcript13 Aug 2025
- Link of Recording8 Aug 2025
- Transcript27 May 2025
- Link of Recording20 May 2025
- Transcript18 Feb 2025
- Link of Recording14 Feb 2025
- Transcript26 Nov 2024
- Link of Recording19 Nov 2024
- Transcript20 Aug 2024
- Link of Recording13 Aug 2024
- Transcript21 May 2024
- Link of Recording16 May 2024
- Transcript14 Feb 2024
- Link of Recording8 Feb 2024
- Transcript16 Nov 2023
- Link of Recording9 Nov 2023
- Transcript19 Aug 2023
- Link of Recording16 Aug 2023
- Transcript of Earnings Conference Call, post declaration of audited financial results for the quarter and year ended 31st March 202317 May 2023
- Link of Audio Recording of Analysts/Investors Call pertaining to the Financial Results 4Q & FY2310 May 2023
- Transcript13 Feb 2023
- Link of Recording9 Feb 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call19 Nov 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call16 Nov 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call16 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call10 Aug 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call7 Jun 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call1 Jun 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call22 Feb 2022
- Transcript22 Nov 2021
- Transcript of Earnings Conference Call, post declaration of audited financial results for the quarter and nine months period ended 31st December 20201 Mar 2021
- Transcript of Earnings Conference Call for quarter and half year ended 30th September 20202 Dec 2020
IOL Chemicals and Pharmaceuticals merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
IOL Chemicals and Pharmaceuticals share news and announcements
Newest first. Page 1 of 15.
Oct 2026
30 Oct · Results
28 Oct · Analysts
23 Oct · Board meeting
Sep 2026
23 Sep · Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
23 Sep · Analysts
23 Sep · Analysts
21 Sep · General Updates
10 Sep · Analysts
9 Sep
Aug 2026
26 Aug · Analysts
10 Aug · Results
7 Aug · Analysts
3 Aug · Board meeting
Jul 2026
14 Jul
1 Jul · Rating
Jun 2026
11 Jun
10 Jun
May 2026
22 May · Analysts
20 May · Results
18 May · Analysts
13 May · Board meeting
12 May · Legal
The exchange asked on 11 May 2026
9 May
Apr 2026
9 Apr
1 Apr
Mar 2026
11 Mar · Legal
Exchange has sought clarification from IOL Chemicals and Pharmaceuticals Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act. -2. 2013 or as per Indian Accounting Standard. The response of the Company is awaited.6 Mar
2 Mar
Feb 2026
24 Feb
12 Feb
11 Feb · Corporate action
4 Feb · Analysts
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 10 Aug 2026Resultsdown 1.90%−2.0 pts vs Nifty 500market median −0.7% · five sessions −1.4% (−0.9 pts vs Nifty 500) · volume 5.1× usual · delivery −15.1 pts against usual · The announcement
- 2 Jul 2026Credit ratingup 2.11%+1.4 pts vs Nifty 500market median 0.0% · five sessions +13.5% (+14.4 pts vs Nifty 500) · volume 1.2× usual · delivery +3.6 pts against usual · The announcement
- 20 May 2026Resultsup 8.55%+8.3 pts vs Nifty 500market median −0.7% · five sessions +23.6% (+21.9 pts vs Nifty 500) · volume 6.2× usual · delivery −16.0 pts against usual · The announcement
- 11 Feb 2026Resultsdown 6.98%−7.1 pts vs Nifty 500market median −0.7% · five sessions −7.9% (−7.0 pts vs Nifty 500) · volume 3.6× usual · delivery −0.7 pts against usual · The announcement
- 12 Nov 2025Resultsup 10.93%+10.3 pts vs Nifty 500market median −0.7% · five sessions +5.3% (+4.7 pts vs Nifty 500) · volume 23.0× usual · delivery −32.2 pts against usual · The announcement
- 7 Aug 2025Resultsup 3.04%+2.9 pts vs Nifty 500market median −0.7% · five sessions −2.0% (−2.1 pts vs Nifty 500) · volume 1.6× usual · delivery −18.3 pts against usual · The announcement
- 2 Jul 2025Credit ratingdown 0.96%−0.7 pts vs Nifty 500market median 0.0% · five sessions −4.9% (−4.7 pts vs Nifty 500) · volume 0.9× usual · delivery −0.5 pts against usual · The announcement
- 19 May 2025Board or managers changedup 1.45%+1.5 pts vs Nifty 500market median 0.0% · five sessions +7.6% (+7.9 pts vs Nifty 500) · volume 2.7× usual · delivery −5.6 pts against usual · The announcement
- 13 Feb 2025Dividenddown 1.44%−1.4 pts vs Nifty 500market median 0.0% · five sessions −6.9% (−6.1 pts vs Nifty 500) · volume 0.8× usual · delivery +9.0 pts against usual · The announcement
- 18 Nov 2024Resultsdown 6.10%−5.8 pts vs Nifty 500market median −0.7% · five sessions −5.0% (−7.7 pts vs Nifty 500) · volume 2.4× usual · delivery +7.0 pts against usual · The announcement
20 earlier announcements
- 31 Oct 2024Credit ratingup 0.60%+0.9 pts vs Nifty 500market median 0.0% · five sessions +2.9% (+1.7 pts vs Nifty 500) · volume 0.4× usual · delivery −2.6 pts against usual · The announcement
- 19 Sep 2024Board or managers changeddown 4.04%−3.9 pts vs Nifty 500market median 0.0% · five sessions −2.1% (−4.0 pts vs Nifty 500) · volume 0.8× usual · delivery −5.8 pts against usual · The announcement
- 12 Aug 2024Resultsdown 0.87%−0.8 pts vs Nifty 500market median −0.7% · five sessions −1.8% (−2.8 pts vs Nifty 500) · volume 0.9× usual · delivery −3.1 pts against usual · The announcement
- 27 Jun 2024Credit ratingup 0.32%−0.1 pts vs Nifty 500market median 0.0% · five sessions +7.2% (+5.4 pts vs Nifty 500) · volume 0.4× usual · delivery +1.3 pts against usual · The announcement
- 7 Feb 2024Dividenddown 5.56%−5.9 pts vs Nifty 500market median 0.0% · five sessions −10.2% (−9.0 pts vs Nifty 500) · volume 2.9× usual · delivery +6.9 pts against usual · The announcement
- 9 Nov 2023Resultsdown 4.60%−4.4 pts vs Nifty 500market median −0.7% · five sessions −4.3% (−5.7 pts vs Nifty 500) · volume 1.9× usual · delivery +3.4 pts against usual · The announcement
- 10 Aug 2023Resultsdown 1.61%−1.2 pts vs Nifty 500market median −0.7% · five sessions −5.1% (−3.9 pts vs Nifty 500) · volume 1.8× usual · delivery −1.5 pts against usual · The announcement
- 30 Jun 2023Credit ratingup 0.61%−0.3 pts vs Nifty 500market median 0.0% · five sessions −8.3% (−10.9 pts vs Nifty 500) · volume 0.8× usual · delivery +3.9 pts against usual · The announcement
- 28 Apr 2023Resultsdown 6.62%−7.6 pts vs Nifty 500market median −0.7% · five sessions −7.0% (−8.3 pts vs Nifty 500) · volume 1.9× usual · delivery −4.2 pts against usual · The announcement
- 8 Feb 2023Dividenddown 2.30%−3.2 pts vs Nifty 500market median 0.0% · five sessions −3.7% (−4.2 pts vs Nifty 500) · volume 1.2× usual · delivery −4.5 pts against usual · The announcement
- 10 Aug 2022Resultsdown 1.83%−1.8 pts vs Nifty 500market median −0.7% · five sessions +1.0% (−1.6 pts vs Nifty 500) · volume 1.0× usual · delivery +0.4 pts against usual · The announcement
- 5 Jul 2022Credit ratingdown 0.39%−0.3 pts vs Nifty 500market median 0.0% · five sessions +5.2% (+2.1 pts vs Nifty 500) · volume 0.5× usual · delivery −1.7 pts against usual · The announcement
- 31 May 2022Resultsdown 7.21%−7.0 pts vs Nifty 500market median −0.7% · five sessions −12.6% (−11.9 pts vs Nifty 500) · volume 4.1× usual · delivery +15.7 pts against usual · The announcement
- 7 Feb 2022Dividenddown 4.69%−3.3 pts vs Nifty 500market median 0.0% · five sessions −10.1% (−8.8 pts vs Nifty 500) · volume 1.7× usual · delivery −0.1 pts against usual · The announcement
- 15 Nov 2021Resultsdown 7.43%−7.5 pts vs Nifty 500market median −0.7% · five sessions −15.5% (−11.6 pts vs Nifty 500) · volume 6.6× usual · delivery +0.6 pts against usual · The announcement
- 16 Aug 2021Resultsdown 7.50%−7.5 pts vs Nifty 500market median −0.7% · five sessions −15.6% (−14.7 pts vs Nifty 500) · volume 1.7× usual · delivery +2.1 pts against usual · The announcement
- 6 Jul 2021Credit ratingdown 1.01%−0.9 pts vs Nifty 500market median 0.0% · five sessions 0.0% (+0.2 pts vs Nifty 500) · volume 1.6× usual · delivery −7.3 pts against usual · The announcement
- 7 Jun 2021Dividenddown 6.16%−6.8 pts vs Nifty 500market median 0.0% · five sessions −5.9% (−7.1 pts vs Nifty 500) · volume 2.3× usual · delivery +3.8 pts against usual · The announcement
- 31 May 2021Dividendup 5.05%+4.2 pts vs Nifty 500market median 0.0% · five sessions +5.1% (+3.0 pts vs Nifty 500) · volume 2.5× usual · delivery +3.1 pts against usual · The announcement
- 1 Apr 2021Board or managers changedup 0.28%−1.1 pts vs Nifty 500market median 0.0% · five sessions +10.7% (+8.9 pts vs Nifty 500) · volume 0.7× usual · delivery +7.6 pts against usual · The announcement
IOL Chemicals and Pharmaceuticals results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.